• 무역학회지
• /
• 제47권4호
• /
• pp.53-68
• /
• 2022

It has great significance to estimate CIF-FOB margins of international trade. It certainly helps develop statistics on transport costs of international trade and provides basic data for econometric analysis of transport costs. It also contributes much to our standing the correlation between the margins and trade partners' geographical distance as well as one between the margins and trading products. However, the quality issue of international trade statistics renders it very difficult to derive trustworthy CIF-FOB margin estimates. Utilizing various analytical approaches, this study intended to acquire credible estimates of CIF-FOB margins for Korea's total imports and for country/product specific imports data. Major findings are as follows. First, the average of CIF-FOB margins of Korea's total imports is 7.3% and is generally declining. Second, country level analysis provides credible estimates for CIF-FOB margins of Korea's imports from four partners (Japan, the US, Australia, and Brazil). The differences in margins among these four countries are caused by geographical distance and characteristics of traded products. Third, product level analysis reveals that the margins of gold and passenger vehicles are fairly low while those of primary products tend to be high.

• 분석과학
• /
• 제17권3호
• /
• pp.211-216
• /
• 2004

본 연구는 분변 잠혈 검출 키트 (one-step FOB(Fecal Occult Blood) kit)가 법생물학적으로 매우 중요한 혈흔 검출 및 사람 혈흔 판정에 적용 가능한지 알아보고자 하였다. 먼저 FOB 키트의 민감도를 결정하고 기존의 혈흔 검사법인 LMG 검사와 비교한 결과 1,000,000배 희석된 혈액까지도 검출 되었는데 이는 LMG 검사에 비해 약100배 정도 예민한 것이었다. 다른 동물 혈액에 대한 교차 반응 여부를 실험한 결과 FOB 키트는 사람의 혈액과만 반응하여 높은 특이성을 보여주었다. 또한 혈액의 보관 온도 및 경과 시간의 영향, 고온 처리의 영향을 알아보았으며, LMG 및 Luminol 시약의 영향에 대해서도 실험하였다. 사람 혈액 특이 항원은 매우 높은 안정성을 보여주었으며, 전통적인 혈흔 검사 시약인 LMG 및 Luminol에 대해서도 영향을 받지 않았다. 따라서 FOB 키트는 LMG 검사 및 Luminol 검사와 병행하여 사용하면 보다 신속하고 정확하게 사람 혈흔 여부를 판정할 수 있어 법과학 실험실에서는 물론 사건 현장에서의 혈흔 검사에 크게 기여할 수 있을 것으로 사료된다.

• 한국식품영양과학회지
• /
• 제34권9호
• /
• pp.1367-1374
• /
• 2005

사람의 정상 골모세포 FOB에서 아미노산 수송계 L의 발현 및 이들 수송계 L을 통한 아미노산 수송특성을 밝히기 위하여, FOB 세포에서 RT-PCR, western blot 분석 및 아미노산 uptake 실험 등을 수행하여 다음과 같은 결과들을 얻었다. FOB 세포에서 아미노산 수송계 L의 두 아형인 LAT1, LAT2및 그들의 보조인자 4F2hc의 발현을 확인할 수 있었다. FOB 세포에서 $_{L}-leucine$의 수송은 $Na^+$-비의존적이었다. FOB 세포에서 $_{L}-leucine$의 수송은 아미노산 수송계 L의 선택적 억제제인 BCH에 의해 완전히 차단되었다. FOB 세포에서 여러 아미노산들에 의한 L-leucine수송억제 실험결과는 Xenopus oocyte에서 시행되어 보고되어진 LAT1과 LAT2 수송억제 실험 결과의 특성을 모두 포함하였다. 본 연구의 결과로 사람의 정상 골모세포주인 FOB에서 는 세포성장 및 증식을 위한 중성 아미노산의 수송에 아미노산 수송계 L의 두 아형인 LAT1과 LAT2가 중요한 역할을 하고 있음을 확인할 수 있었다.

• 한국중재학회지:중재연구
• /
• 제21권3호
• /
• pp.189-211
• /
• 2011

This article aims at analysing the practical problems of FOB and CIF terms relating to Incoterms$^{(R)}$2010 in case of L/C transactions and presenting the defending measures against them. According to Incoterms$^{(R)}$2010, FOB and CIF terms are to be used only for sea or inland waterway transport and require the seller deliver the goods on board the vessel nominated by the buyer at named port of shipment. So if FOB and CIF terms will be used in sea transport under L/C transaction, the seller should ship the goods on the nominated vessel and present the shipping document indicating "on board vessel" to the issuing bank but the parties agree to present the received bill of lading according to special condition on L/C which is" received bill of lading are acceptable". In practical transaction, FOB and CIF terms are usually used in aircraft cargo, container cargo or multimodal transport. these facts are a violation of Incoterms. Incoterms$^{(R)}$2010 which regulated that FOB and CIF terms may not be appropriate where goods are handed over the carrier before they are on board the vessel for example goods in container. These transactions are a temporary expedient and breach of Incoterms in the international trade which must be corrected as soon as possible.

• Journal of Applied Biological Chemistry
• /
• 제53권4호
• /
• pp.212-218
• /
• 2010

연구는 전통발효공정에 따라 오미자를 발효시켜 제조한 오미자 발효액의 여러 가지 생리활성에 대하여 조사하였다. 우선, 오미자 발효액의 일반성분, 무기질 및 비타민 분석을 시행한 결과에서 발효전의 오미자보다 탄수화물과 비타민 C 함량이 높게 나타났다. 또한, 주요 맛 성분인 유리당 함량을 측정한 결과, 오미자 발효액에서 glucose와 fructose 함량이 발효 전의 오미자 보다 높게 나타났다. 이에 반해, 발효 전 오미자에서 검출되는 sucrose가 오미자 발효액에서는 나타나지 않았다. 오미자 발효액의 항산화 효과를 분석하기 위해 DPPH radical 소거능을 측정한 결과, 4배 희석한 오미자 발효액 (25%)에서 79.7%의 DPPH radical 소거능을 나타내었는데, 0.01%의 BHA와 유사한 항산화력이 측정되었다. 또한 오미자 발효액의 94.7%의 C의 경우 농노 0.1%일 때 98.1%로 보고되어 있어 오미자 발효원액(100%)과 유사한 항산화능을 나타내고 있다. 이것으로 볼 때 오미자 발효액의 항산화 활성이 아주 높은 것으로 항산화력에 관한 높은 이용가치를 의미한다. 또한, 오미자 발효액의 항균활성을 관찰한 결과 오미자 발효원액 (100%)에서 E. coli에 대한 항균효과가 나타났다. Tyrosinase의 저해효과는 사료의 농도가 증가함에 따라 유의적으로 증가하는 경향을 나타내었는데 50% 농도의 오미자 발효액에서 82%의 높은 tyrosinase 억제효과를 나타내었다. 오미자 발효액의 피부 주름 예방효과를 측정하기 위하여 elastasc 저해효과 실험을 실시한 결과 전반적으로 농도가 높아짐에 따려 비례적으로 저해활성이 증가하였다. 이상의 결과는 오미자 발효액의 우수한 생리활성을 증명하고 있고, 항산화능, 항균력, 피부미용 효과가 높은 것으로 나타나 기능성 음료의 소재로서 그 활용도가 높을 것으로 판단된다.

• 대한간호학회지
• /
• 제20권3호
• /
• pp.300-306
• /
• 1990

Colorectal cancer is second only to lung cancer as a cause of death due to cancer in the united States. Studies have shown that fecal occult blood(FOB) tests are effective in detecting colorectal cancer in its early stages. To motivate worksite FOB testing, a randomized controlled trial was conducted. Employees 40 years or older from three federal agencies in Washington State were randomized to a control group(n＝139) which received a letter stating the availability of the FOB test at the worksite clinic or to an intervention group(n＝139) which received the letter about facts on colorectal cancer and a Colorectal Cancer Risk Appraisal. The Colorectal Cancer Risk Appraisal included a feedback on an individual's risk of developing colorectal cancer compared to his / her peers in terms of ‘normal’, ‘moderate’, or ‘high’ risk status. After 3 months, a follow-up questionnaire was sent to all participants to measure the effectiveness of the intervention. In the analysis of the three major outcomes, two possible confounding factors(dietary fat and family history of colorectal cancer) were controlled by logistic regression. Based on a review of the worksite clinic records, the Intervention group had 4.3% higher compliance rate with the FOB test during the follow-up period compared to the control group(p＝.10). The largest effect of the intervention was on the employees' intention to get a FOB test within the next year(62.6% in the intervention group vs. 36.2% in the control group, OR＝3.18, p＜.001). In the final Multivariate logistic model, the employees who were more likely to intend to get a FOB test within the next year were in the intervention group ; were at ‘moderate’ or ‘high’ risk of colorectal cancer ; knew more about the availability of the FOB test at the worksite clinic ; and had a FOB test during the last three years.

• 무역상무연구
• /
• 제58권
• /
• pp.35-58
• /
• 2013

In Mash & Murrell, Diplock J said that "there is an implied warranty not merely that they shall be merchantable at the time they are put on the vessel, but that they shall be in such a state that they can endure the normal journey and be in a merchantable condition upon arrival." But in The Mercini Lady, Field J said that "the goods would be of satisfactory quality not only when the goods were delivered on to the vessel but also for a reasonable time thereafter." and "The proposed conditions were not excluded by clause 18. ${\cdots}$ clause 18 was not to be construed as extending to conditions ${\cdots}$". In relation to the problems on validity of the goods conformity clauses in FOB contracts, when considering Lord Wright's comments ("${\cdots}$ hence apt and precise words must be used to exclude it: the words guarantee or warranty are not sufficiently clear.") in Cammell Laird & Co Ltd v Manganese Bronze and Brass, FOB contracts are fundamentally one that seller's duty to deliver the goods is completing at the port of shipment and "principle of party autonomy" in Contract Law, I do not think that the terms implied by section 14 of the SGA and Common Law cannot absolutely excluded by the goods conformity clauses in sale contracts. Therefore, in order to exclude the implied terms, the parties must very clearly spell out this in the relevant clauses.

• 무역상무연구
• /
• 제11권
• /
• pp.185-204
• /
• 1998

• 비료회보
• /
• 통권48호
• /
• pp.6-7
• /
• 1977

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제15권3호
• /
• pp.167-171
• /
• 2015

When anesthesiologists encounter conditions in which intubation is not possible using a conventional direct laryngoscope, they can consider using other available techniques and devices such as fiber optic bronchoscope (FOB)-guided intubation, a laryngeal mask airway (LMA), intubating LMA (ILMA), a light wand, and the Combitube. FOB-guided intubation is frequently utilized in predicted difficult airway cases and is generally performed when the patient is awake to enable easier access to the trachea. An LMA can be introduced to ventilate the patient with relative ease, while an ILMA can be used for definite endotracheal intubation. However, occasionally, an endotracheal tube (ETT) cannot pass through the larynx, despite successful introduction of a FOB into the trachea and placement of an ILMA by the anesthesiologist. Therefore, we initially introduced an ILMA for emergent ventilation, followed by successful insertion of an ETT under FOB guidance. In this report, we describe three cases of difficult intubation using a FOB and ILMA combination approach.